v3.26.1
Note 14 - Stock Based Compensation
12 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

NOTE 14 STOCK BASED COMPENSATION

 

The Company’s 2017 OSP was adopted by the Company’s BOD on February 24, 2017, and approved by the Company’s shareholders at the May 25, 2017, Annual Meeting of Shareholders. The 2017 OSP enables the Company to grant stock incentive awards to current and new employees, including officers, and to BOD members and service providers. The 2017 OSP permits stock incentive awards in the form of Options (incentive and non-qualified), stock appreciation rights, restricted stock, RSUs, performance stock, performance units, and other awards in stock or cash. The 2017 OSP permits the issuance of up to 625,000 shares of our Common Stock in any of the above stock awards. As of December 31, 2025, 37,809 shares remain available for future grants under the 2017 OSP.

 

Option Awards

 

Prior to 2025, the Compensation Committee granted non-qualified stock Options The Compensation Committee believed that grants of Options more directly align management long-term equity compensation with increased shareholder value creation at a time when the Company is engaged in significant investment and transformation as part of its long-term strategy. The Compensation Committee also determined to extend the grant of Options to include Named Executive Officers, senior employee directors and other employee directors as key members of the Company leadership team and contributors to overall success.

 

As previously disclosed, the number of Options awarded was computed as a percentage of the employee’s base salary using a Black-Scholes formula using an exercise price equal to the closing price of Company common stock of $11.00 on March 28, 2024, 14.70 on March 31, 2023, and $21.20 on April 11, 2022. The 2024 Options will vest one-third each on March 28, 2025, 2026 and 2027. The 2023 Options will vest one-third each on March 31, 2024, 2025 and 2026. The 2022 Options will vest one-third each on April 11, 2023, 2024 and 2025.

 

           

Closing

   
           

Stock

 

Vesting

   

Options

   

Price

 

Date

Balance at December 31, 2021

    -            

Issued

    40,577     $ 21.20  

4/11/2023

Issued

    40,583     $ 21.20  

4/11/2024

Issued

    40,583     $ 21.20  

4/11/2025

Balance at December 31, 2022

    121,743            

Issued

    51,431     $ 14.70  

3/31/2024

Issued

    51,431     $ 14.70  

3/31/2025

Issued

    51,432     $ 14.70  

3/31/2026

Balance at December 31, 2023

    276,037            

Issued

    35,817     $ 11.00  

3/28/2025

Issued

    35,818     $ 11.00  

3/28/2026

Issued

    35,818     $ 11.00  

3/28/2027

Balance at December 31, 2024

    383,490            

Forfeited

    (27,482 )          

Balance at December 31, 2025

    356,008            

 

The grant date fair value of employee stock Option awards is determined using the Black Scholes Option-pricing model. The following assumptions were used during the following periods:

 

   

2024 Grants

   

2023 Grants

   

2022 Grants

 
                         

Exercise Price

  $ 11.00     $ 14.70     $ 21.20  

Risk-Free Rate of Interest

    3.866 %     2.957 %     1.515 %

Expected Term (Years)

    10       10       10  

Expected Stock Price Volatility

    36.6 %     20.7 %     18.1 %

Dividend Yield

    2.11 %     2.83 %     2.44 %

 

The following table summarizes the Company’s employee stock Option activity under the 2017 OSP, which was approved by the Company’s shareholders, for the following periods:

 

                   

Weighted

         
           

Weighted

   

Average

   

Aggregate

 
   

Number of

   

Average

   

Remaining

   

Intrinsic

 
   

Shares

   

Exercise Price

   

Term (Years)

   

Value

 

Outstanding as of December 31, 2021

    -     $ -       -     $ -  

Granted

    121,743       21.20       6.28       -  

Forfeited

    -       -       -       -  

Outstanding as of December 31. 2022

    121,743     $ 21.20       6.28     $ -  

Granted

    154,294       14.70       7.25       -  

Forfeited

    -       -       -       -  

Outstanding as of December 31, 2023

    276,037     $ 17.57       6.83     $ -  

Granted

    107,453       11.00       8.25       322,359  

Forfeited

    -       -       -       -  

Outstanding as of December 31, 2024

    383,490     $ 15.73       7.18     $ 322,359  

Granted

    -       -       -          

Forfeited

    (27,482 )     13.60               (43,995 )

Outstanding as of December 31, 2025

    356,008       16.96       7.18       278,364  

Exercisable as of December 31. 2025

    256,185     $ 18.13       6.93     $ 103,995  

 

The weighted average grant date fair value per share for employee stock and non-employee Option grants issued on March 28, 2024, was $4.34. The weighted average grant date fair value per share for employee stock and non-employee stock Option grants issued on March 31, 2023, was $2.90. The weighted average grant date fair value per share for employee stock and non-employee Option grants issued on April 11, 2022, was $3.24. As of December 31, 2025, the total unrecognized compensation related to unvested employee and non-employee stock Option awards granted was $187,017, which the Company expects to recognize over a weighted-average period of approximately 1.07 years. As of December 31, 2024, the total unrecognized compensation related to unvested employee and non-employee stock Option awards granted was $571,335, which the Company expects to recognize over a weighted-average period of approximately 1.79 years.

 

On March 13, 2023, the Company BOD adopted changes to the Nuvera Communications, Inc. 2017 OSP. Most of the changes eliminate language specific to the requirements and limitations on grants under Internal Revenue Code Section162 (m), which has been repealed by Congress. This includes provisions related to “Performance-Based Exception” in several sections of the 2017 OSP. The BOD also increased the limit on annual grants from 50,000 to 100,000 shares per participant and eliminated separate provisions on new-hire stock grants and cash-based grants. The BOD also made minor changes to other sections of the 2017 OSP. The BOD did not increase the number of shares authorized for issuance under the 2017 OSP or change the terms of eligibility for participants under the 2017 OSP. The foregoing description of the changes to the 2017 OSP does not purport to be complete and is qualified in its entirety by reference to the full text of the 2017 OSP, as amended, which is filed as Exhibit 10.12 to the 2022 Annual Report on Form 10-K and is incorporated by reference.